Dr. Anna Maria Lavezzi, graduated in Biological Sciences and Medicine, is Associate Professor of Pathology at the Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy. She is Scientific Director of the “Lino Rossi” Research Center for the study and prevention of unexpected perinatal death and sudden infant death syndrome (SIDS), University of Milan, Italy. She is member of the International Stillbirth Alliance and has major international collaborations (as with the Center for Autonomic Medicine in Pediatrics of the Children’s Memorial Hospital, Chicago, USA; the Department of Neurosurgery and Molecular Pharmacology of the Brown University Medical School, Providence, Rhode Island, USA, and the Department of Environmental Medicine of the University of Rijeka, Croatia). She is author of many publications (over 250), mainly concerning the neuropathology of the sudden perinatal death, in international journals ad high impact factor.

Dr. Daniela Fanni received her medical resident and fellowships training at the University of Cagliari Medical School and her Ph.D. Degree in Lolecular and Experimental Oncology at the University of Pisa. She currently is an associate professor of Pathology at University of Cagliari Medical School and she works as a pathologist at the University Hospital of Cagliari. She has published more than 100 peer reviewed research articles, reviews and book chapters. Her research is focused on pathology, stem cells, perinatal pathologist, cancer, hemolymphopathology, gastrointestinal pathology, liver disease, soft tissue tumors, COVID-19, atherosclerosis.

Dr. Liam Chen received his medical resident and fellowships training at Harvard Medical School. He is currently the director of Neuropathology and associate professor of Laboratory Medicine and Pathology and Neurosurgery at University of Minnesota Medical School. He has published nearly 100 peer reviewed research articles, reviews and book chapters. His research is focused on understanding the pathogenesis of brain and spinal cord tumors and neurodegenerative disorders, developing diagnostic biomarkers and validating therapeutic targets.

Dr. Iavarone Federica is currently working as researcher in Catholic University of Sacred Heart School of Medicine. In 2010 obtained with full merit the Specialization in Clinical Biochemistry at the Medicine Faculty of the Catholic University of Sacred Heart in Rome. Her research goals are in the field of human proteomics, in particular in the identification of biomarkers in different biological fluids as saliva and urine. She has over 50 papers published in refereed journals.

Dr. Shicheng Guo received his Ph.D. degree from Fudan University in 2015. After the post-doctoral training at University of Texas Health Science Center at Houston (UT Health) and University of California, San Diego (UCSD), Dr. Guo joined Center for Precision Medicine Research at the Marshfield Clinic Research Institute. Dr. Guo made series of contribution on Human PBMC methylome, Silk methylome and tissue- of-origin mapping by cell-free circulating DNA methylation. Now, he is focusing on genetic epidemiology and the diagnostic and prognostic roles of epigenetic variations in human complex disease, especially human autoimmune disease and cancer. In the Marshfield Clinic, Dr. Guo has made full use of his bioinformatics, big data analysis and text mining skills to valuable Marshfield Personalize Medicine Research Project dataset (including 20,000 Exome-chip data and comprehensive clinical and epidemiological information) and Roadmap, Blueprint, Encode project to identify disease susceptibility genes and epigenetic markers for early diagnosis or real-time prognosis surveillance.

Huangxian Ju, B.S., M.S. and Ph.D in 1986, 1989 and 1992, and lecturer, associate professor and professor in 1992, 1993 and 1999 at Nanjing University, is currently the director of State Key Laboratory of Analytical Chemistry for Life Science. He won the National Funds for National Distinguished Young Scholars in 2003 and was selected as a Changjiang Professor by Education Ministry of China in 2007 and became Fellows of the International Society of Electrochemistry and the Royal Society of Chemistry in 2015. He published 632 papers, 3 English books, 7 Chinese books with >26300 citations and h-index of 84 (Google Scholar h-index 95 with 31302 citations) up to Oct 20, 2018.

Dr. Mahmood Khan received broad academic training and solid research experience in the fields of cardiovascular pharmacology/physiology, extracellular vesicles, regenerative medicine and bioengineering. He has 15 years of experience in the areas of cardiovascular research for treating myocardial infarction and cardioprotection with antioxidant compounds. One of his major long-term research interests centers on translation of stem-cell therapy for myocardial repair in patients with heart failure. He has published over 80 peer-reviewed papers and 8 text-book chapters, a majority of them are focused on cardioprotection and stem-cell therapy. He is currently serving as a PI in NIH grant, the main goal of this proposal is to establish electrospun nanofiber scaffolds for cardiac regeneration and promote angiogenesis in the ischemic heart via incorporating growth factors in the scaffold.

Dr. Annat Raiter completed her PhD in immunology of reproduction at The Institute of Biology and Experimental Medicine (IBYME), School of Medicine, University of Buenos Aires, Argentina. She is the Scientific Director of the Breast Cancer Research lab, at the Felsenstein Medical Research Center, Tel Aviv University, Rabin Medical Center, Israel. Dr. Raiter is a PI in an innovative immuno-oncology project. She has extensive research experience in the fields of immunology, immune-oncology and angiogenesis that resulted in the publication of a number of scientific papers in prestigious peer review journals and invention of numerous patents.

Elia Ranzato is cell biologist involved in characterization of cellular and molecular responses during wound healing and tissue regeneration processes.

Michele Yip-Schneider received her PhD in Biochemistry from the University of California, Davis. Following post-doctoral training at the University of California, Los Angeles and Indiana University School of Medicine, she joined the Department of Surgery faculty at Indiana University School of Medicine in 2001. Her training in molecular biology and human disease provides the foundation and expertise to pursue current translational studies in pancreatic cancer.

Dr. Wei Wu is an Associate Professor and Associate Department Chair in the Department of Toxicology at Nanjing Medical University, China, where he received his Ph.D. in Toxicology in 2012. He was a guest researcher at the National Institute of Environmental Health Sciences (NIEHS) between 2017 and 2018. His research interests include epigenetic mechanisms of transgenerational effects of male infertility induced by endocrine disrupting chemicals, environmental exposure, and male reproductive health, genetic and epigenetic risk factors of male infertility and abnormal fetal growth. Prof. Wu has authored 70 peer-reviewed papers in international journals such as EBioMedicine, Clinical Epigenetics, Environment International, Toxicological Sciences, Scientific Reports, Human Reproduction, and Molecular Human Reproduction.

Dr. Francesca Duraturo received a PhD in Biochemistry and Molecular and Cellular Biology from the University of Naples Federico II in January 2006. She was awarded the title of Medical Genetic Specialist, 70/70 summa cum laude, by the University of Rome La Sapienza in November 2009. Her research interest mainly focuses on the molecular basis of hereditary colorectal cancer. She is the author of a number of scientific publications. Dr. Duraturo has memberships in scientific societies including the Italian Association for the Study of Familiarity and Inheritance of Gastrointestinal Tumors (A.I.F.E.G.) and Italian Society of Biochemistry (SIB).

Dr. Simmi Kharb is a Nodal Officer at Multidisciplinary Research Unit in Pt. B. D. Sharma PGIMS, University of Health Sciences, Rohtak. Her research interest mainly focuses on Preeclampsia, free radical, cord blood, cancer, congenital anomalies, pollution, diabetes, and cardiovascular diseases. She has authored/co-authored more than 200 scientific papers and 7 books.

Dr. Sherief Abd-Elsalam did M.S. in Tropical Medicine and Infectious diseases from the Faculty of Medicine, Tanta University, Egypt in 2007. He obtained his PhD in Tropical Medicine and Infectious diseases from the Faculty of Medicine, Tanta University, Egypt in 2013. He is currently working as an Assistant Professor of Tropical Medicine and Infectious diseases department – Tanta University Faculty of Medicine, Egypt.

Dr. Ricardo David Couto graduated in Pharmacy (1998) and he also obtained a Master’s degree and Ph.D. in Pharmacy (Clinical Analysis) degree from University of São Paulo (2000 - 2005). He is currently working as an Associate Professor III position at UFBA. He has a vast experience in the area of Laboratory Diagnosis of Diseases, with emphasis on validation and development of diagnostic tests, lipoproteins, human and experimental atherosclerosis. His areas of expertise are Health Sciences and particularly Pharmacy (subareas are lipídios, lipoproteínas e aterosclerose experimental). Dr. Couto has published around 50 articles in Scientific Journals so far.

Dr. Khalid El Bairi is affiliated with Mohammed 1st University is currently affiliated with Faculty of Medicine and Pharmacy, Cancer Biomarkers Working Group, Gynecologic Oncology and Cancer Biology, Oujda, Oriental, Morocco. His research work is a part of the scientific activities of recently launched Cancer Biomarkers Working Group (which focuses on various areas in cancer biomarkers covering TILs, genomic signatures, and proteomic markers). He has around 10 selected publications to his credit so far.

Dr. Chen is a pioneer in identifying biomarkers in distal body fluid of lung cancer patients by taking advantages of genetically engineered mouse model. One important goal of his lab is to predict the genotyping of the lung cancer by the biomarker information identified in patients’ urine. His research interest extends in precision medicine and driving molecular events underlying lung cancer tumorigenesis.

Dr. Biswaranjan Paital is presently serving as an Assistant Professor of Zoology at CBSH, Orissa University of Agriculture and Technology. He obtained PhD in Zoology in 2010 from Utkal University, Bhubaneswar, Odisha,India. He is an Editorial member of different journals such as Journal of Environmental and Occupational Science, Research journal of Biology, American Journal of Life Sciences, and many other journals. He has contributed his valuable publications in different journals. He is also a reviewer in Scopus/PubMed Listed International Journals. He also attended National and International conferences.

Dr. R.K.Poopal, completed MSc, MPhil, PhD, Diploma in Zoology from theBharathiar University, Coimbatore, and NPDF (DST-SERB) at Bharathidasan University, Tiruchirappalli, TN, India. He serves as Scientific Researcher and Foreign Expert, Institute of Environment and Ecology, Shandong Normal University, Jinan, China, and Editorial board member for The Open Biomarkers Journal. He is also an editorial board member in four journals. He published more than 20 research articles in SCI journals. More than 15 journals have invited him as a peer reviewer. His research area is Eco-Toxicology, impact assessment of waterborne contaminants in fish. He focuses on the determination of LC50, monitoring behaviour and biomarkers responses of fish to waterborne contaminants.

Amit Kumar Srivastava earned his Bachelor’s in Pharmacy (2010) from Bharat Institute of Technology, Meerut, India and Master’s in Pharmacology (2013) from Truba Institute of Pharmacy, Bhopal, India. His research interest focuses on the development of novel strategies for the diagnosis, treatment and prevention of infectious and autoimmune diseases. He has expertise in conducting in vivo studies of the drug molecules in the early preclinical development phase. He has authored 33 scientific publications in peer-reviewed scientific journals and also serving as an editorial board member and peer reviewer in scientific journals of repute. He is a member of many learned societies including The Biotech Research Society, India and The Indian Science Congress Association, India.

Dr. Dmitry A. Verbenko obtained his Ph.D. degree (in 2008) in Genetics and Molecular Genetics from the Institute of Molecular Genetics (Russian Academy of Sciences), Department of Molecular Bases of Human Genetics, Moscow, Russia. Presently, Dr. Verbenko is employed as Senior Researcher, STD and Dermatoses Department at State Research Center for Dermatovenereology and Cosmetology (Ministry of Health of Russian Federation), Moscow, Russia. His skills and expertise mainly lie in the subject areas/fields of PCR, Molecular Genetics, Molecular Diagnostics, Human Evolutionary Genetics, Gene Expression Analysis, etc. Dr. Verbenko, as an author/co-author, has published over 15 manuscripts in various journals of international repute.